Pfizer has agreed to supply five million doses of its Covid-19 vaccine to Sri Lanka under a commercial agreement with the State Pharmaceuticals Corporation (SPC), a Minister said yesterday.
State Minister of Production, Supply and Regulation of Pharmaceuticals Prof. Channa Jayasumana told the payment arrangement for the dispatch of Pfizer vaccines would be worked out later.
He said the dose of Pfizer vaccine was smaller than others, and therefore separate syringes will have to be arranged for administering it to people in the country. Besides, he said Sri Lanka had placed orders for 13 million doses of Sputnik V vaccine manufactured in Russia. It is a commercial arrangement between the SPC and Gamaleya Research Institute of Russia. The Minister said the Russian authorities would start the delivery process of the stock in batches starting from the end of this month.
“They will send us the stock in batches during the last week of every month starting from April,†he said. Asked about the regulatory clearance for China’s Sinopharm vaccine, he said it would be given immediately after the World Health Organization (WHO) listed it for emergency use. China has already donated 600,000 doses of this vaccine to Sri Lanka. Commenting on the Covid-19 situation, he said the health authorities were bracing for a spike of the cases by the next week.
While drawing attention to the frequent road accidents caused by buses, the Transport and Highways…
Showers may occur in the Northern, North-Central, Eastern Provinces and in the Matale district, the…
Former Member of Parliament Lalith Ellawala today (27) announced his decision to retire from politics.
The All Share Price Index (ASPI) of the Colombo Stock Exchange has recorded significant gains…
The oral sessions for gathering public opinions on the proposed electricity tariff revision will commence…
A press briefing on the economic stabilization process and the proposed relief packages for the…
View Comments
For India, Pfizer has offered a not-for-profit price for its vaccine for the Government immunization program. While Pfizer was the first company to seek emergency approval in India for its vaccine with BioNTech, its application was rejected because it had not conducted local trials in India.